Since the discovery of specific mechanisms regulating gene transcription, studies have explored therapeutic avenues in the treatment of disease through such epigenetic targets, including the mechanisms of histone acetylation/deacetylation. Indeed, compounds that inhibit histone deacetylation [i.e., histone deacetylase (HDAC) inhibitors] have been investigated as treatments for a variety of diseases, including cancer (1), Alzheimer's disease, and Parkinson disease (2). Considering the role that transcription plays in learning and memory (3), it is not surprising that memory-related diseases and disorders are particularly ripe for treatments based on epigenetic targets. In PNAS, Malvaez et al. (4) report that systemic administration of a selective HDAC3 inhibitor to rats enhances the extinction of cocaineseeking, consistent with previous work (5, 6) . Crucially, they demonstrate that the enhanced extinction is rapid and persistent and even appears to eliminate the reinstatement of cocaine-seeking, suggesting the potential for targeting this mechanism as an adjunctive therapy. Moreover, the authors use a unique behavioral design that enables them to distinguish the effects of the HDAC inhibitor on extinction consolidation from effects on reconsolidation and performance.
In the nuclei of eukaryotic cells, histones function as spools around which DNA is wrapped, serving to provide order and organization to the DNA strands and to regulate transcriptional processes. Histones have long tails extending away from the histone that can be modified, including through acetylation, to permit or repress transcription. Evidence indicates that, in the acetylated state, the nucleosome (histone and DNA together) is "loosened," thereby making the DNA available for transcriptional machinery (Fig. 1) . In contrast, when the acetyl groups are removed, the nucleosomes are "tightened" and transcription is repressed. The relative levels of acetylation are controlled by histone acetyltransferases and HDACs. Compounds that inhibit HDACs have been identified and explored as treatments for a vast array of diseases and disorders. For example, studies have demonstrated that HDAC inhibition improves survival and delays the neuropathology associated with Huntington disease in a mouse model of the disease (7). Alzheimer's disease appears to involve dysregulation of transcription and evidence suggests that administration of an HDAC inhibitor reverses the cognitive impairments in animal models of Alzheimer's disease (8) .
However, HDAC inhibition also has promise as a method for modulating memory processes in conjunction with behavioral therapy. Drug addiction is a particularly insidious disorder that is based on the drugs' modification of normal memory processes. Although extinction therapy for phobias and other similar fear-based disorders is relatively effective (9, 10), extinction treatment alone for drug addiction has remained maddeningly unsuccessful (11, 12) . Thus, an adjunctive therapy that enhances the extinction of drug-based associations in a rapid and persistent manner would be highly beneficial.
In PNAS, Malvaez et al. (4) report on the use of a selective HDAC3 inhibitor (RGFP966) in the enhancement of the extinction of cocaine-seeking behavior. HDAC3 is the most abundant class I HDAC in the brain (13) and has been shown to regulate learning and memory (14) , making it an excellent target for therapeutic treatment. The authors used a conditioned place preference (CPP) paradigm in which mice received repeated injections of cocaine or saline solution paired, respectively, with one of two compartments of a CPP apparatus. This paradigm produced significant preference for the cocaine-paired compartment, a phenomenon often referred to as drug-seeking. The mice underwent three extinction tests, immediately after the first two of which they received a systemic administration of the HDAC3 inhibitor or its respective vehicle. By the second extinction test, those mice receiving the high dose of the inhibitor showed no preference for the cocaine-paired side, and this lack of preference continued during the third extinction test, confirming previous work from their laboratory (5) .
Following additional extinction trials to reduce all groups' CPP, the mice underwent a cocaine-induced reinstatement test, in which they received a single priming injection of cocaine before another test. The vehicle-treated mice displayed significant reinstatement of their cocaine-seeking behavior, whereas those mice that had received the HDAC inhibitor showed no preference at all for the cocainepaired side, indicating that the HDAC inhibitor had not only accelerated the extinction learning but also produced a long-lasting resistance to cocaine-seeking.
A significant difficulty arises in studies on extinction processes, as the experimental manipulation may influence the animal's behavior through effects on the extinction learning, on the reconsolidation of the original memory, or simply on the performance of the animal during subsequent tests. To address this issue, the authors use a clever simultaneous learning paradigm in which the HDAC3 inhibition occurs as the animals engage in the extinction of their CPP learning and in new learning for an objection recognition paradigm. Through this design, the authors demonstrate that the HDAC3 inhibitor's effects on the cocaine-seeking are caused by enhanced extinction, rather than impaired reconsolidation or nonspecific performance effects.
The authors also find that the effects of the HDAC3 inhibitor on extinction appeared to involve molecular changes, including changes in histone acetylation and c-fos expression, in the infralimbic cortex (IFC). These findings add to a body of work indicating that the IFC is critically involved in the extinction learning for a number of different types of learning, including aversive Pavlovian learning paradigms such as fear conditioning (15) and appetitive instrumental learning paradigms such as cocaine self-administration (16) . The accumulation of such studies has begun to point to the IFC as a critical node in a network underlying extinction learning in general, in which cellular and molecular changes within the IFC are likely mediating at least part of extinction learning, although not all studies agree with this conclusion (17) .
The paper by Malvaez et al. (4) therefore represents a multipronged set of innovative experiments that (i) use a clever behavioral design to distinguish between possible competing explanations for the reduction in cocaine-seeking following HDAC3 inhibition; (ii) identify specific neural structures as well as sites of histone modification that may be mediating the effects of HDAC3 inhibition on extinction; and (iii) provide further evidence that HDAC3 inhibition accelerates the extinction of cocaine-seeking, even rendering the animal resistant to cocaineinduced reinstatement. Indeed, the use of pharmaceuticals, such as an HDAC3 inhibitor, in conjunction with extinction training, may significantly increase the efficacy of extinction therapy. However, an interesting question emerges from this study: If HDAC3 inhibition enhances the consolidation of any learning that occurs within the temporal window of the drug's effects, how can we ensure that the consolidation of undesirable memories is not enhanced? Although we do not yet know the answers to such questions, the study by Malvaez et al. (4) represents an important development in the field of epigenetic regulation of drug addiction and a critical effort to open up the treatment of drug addiction to epigenetic therapies.
